GLFD Guilford Pharmaceuticals (MM)

Guilford to Present at UBS Global Life Sciences Conference BALTIMORE, Sept. 22 /PRNewswire-FirstCall/ -- Guilford Pharmaceuticals Inc. (NASDAQ:GLFD) announced today that it will present at the upcoming UBS Global Life Sciences Conference on Tuesday, September 28, 2004 at 1:00 p.m. ET at the Grand Hyatt Hotel in New York, NY. Guilford's Chairman, President and CEO, Craig R. Smith, M.D., will provide an update on the Company's business as well as new developments on products currently in the pipeline. To access the live audio webcast or the subsequent archived recording, log on to http://www.guilfordpharm.com/. The link for the webcast is located under the Investor Relations section of the website under 'Conferences.' Please connect to the website several minutes prior to the start of the conference call to ensure adequate time for any software download that may be necessary. About Guilford Guilford Pharmaceuticals Inc. is a pharmaceutical company engaged in the research, development and commercialization of proprietary drugs that target the hospital and neurology markets. Presently, Guilford markets two commercial products, GLIADEL(R) Wafer (polifeprosan 20 with carmustine implant), for the treatment of brain cancer, and AGGRASTAT(R) Injection (tirofiban hydrochloride), a glycoprotein GP IIb/IIIa receptor antagonist, for the treatment of acute coronary syndrome (ACS). Guilford's product pipeline includes AQUAVAN(R) Injection, a novel sedative/anesthetic and drugs for treating peripheral nerve injury. For full prescribing information, please visit http://www.guilfordpharm.com/ under Products / Marketed Products. CONTACT: Stacey Jurchison, Director, Corporate Communications, Guilford Pharmaceuticals, (410) 631-5022; . http://www.guilfordpharm.com/. DATASOURCE: Guilford Pharmaceuticals Inc. CONTACT: Stacey Jurchison, Director, Corporate Communications, Guilford Pharmaceuticals, +1-410-631-5022, Web site: http://www.guilfordpharm.com/ Company News On-Call: http://www.prnewswire.com/comp/112882.html

Copyright